Is There a Treatment for Vitiligo? Options Explained

Quick Summary

• Vitiligo treatment can restore lost skin colour, but there is currently no permanent cure.
• Topical medicines and phototherapy are commonly used treatment options for vitiligo.
• Ruxolitinib cream is FDA-approved for non-segmental vitiligo in people aged 12 and older.
• Combining treatments, such as ruxolitinib and NB-UVB, may improve repigmentation in some patients.
• Most treatments take months to show noticeable results rather than weeks.
• Surgery may help selected people with stable vitiligo when other treatments have not worked well.

Introduction

White patches on your skin can leave you with plenty of questions: Is it vitiligo? Will it spread? Can the lost colour come back? And is there a treatment that actually works?

There is currently no permanent cure for vitiligo, but that doesn’t mean nothing can be done. Treatment can restore some lost skin colour and may help control further colour loss, although results vary from person to person and usually take time.

This guide explains the main vitiligo treatment options, how they work, what research tells us about their effectiveness, and how long you may need to wait before seeing a difference.

Topical Treatments for Vitiligo

For smaller or localized patches, topical medicines are often among the first treatments considered. These include topical corticosteroids and calcineurin inhibitors such as tacrolimus and pimecrolimus.

These medicines work mainly by reducing the immune activity involved in the destruction of melanocytes, the cells responsible for producing skin pigment.

Topical corticosteroids can help restore skin colour, but because prolonged use can cause side effects such as skin thinning, they are generally prescribed for limited periods and used under medical supervision. Calcineurin inhibitors can be useful on areas such as the face and neck, where prolonged steroid use may be less suitable.

Results vary by body area. Repigmentation tends to be easier to achieve on the face and neck than on areas such as the hands, feet, fingertips, and toes.

Visible improvement usually takes several months, so not seeing a noticeable change after a few weeks does not necessarily mean the treatment has failed.

Ruxolitinib Cream: A Targeted Treatment for Non-Segmental Vitiligo

Ruxolitinib cream is a topical JAK1/JAK2 inhibitor and one of the newer targeted treatment options for non-segmental vitiligo.

In the United States, ruxolitinib cream (Opzelura) is FDA-approved for the topical treatment of non-segmental vitiligo in adults and children aged 12 years and older. It is applied twice daily to affected areas within the labelled body-surface-area limit.

Ruxolitinib works by blocking JAK signalling pathways involved in the immune response associated with vitiligo. Rather than broadly suppressing immune activity, it targets a specific pathway involved in the inflammatory process that contributes to melanocyte loss.

Clinical trials have shown that ruxolitinib can significantly improve facial repigmentation. In the Phase 3 TRuE-V1 and TRuE-V2 trials, 30.7% of patients using ruxolitinib 1.5% cream twice daily achieved at least 75% improvement in facial Vitiligo Area Scoring Index (F-VASI) at week 24, compared with 9.9% using the vehicle cream. These results have also been reviewed in the Indian Journal of Dermatology, Venereology and Leprology.

That timeline is important. Ruxolitinib is not a quick fix. Some people may need more than six months of consistent treatment before seeing substantial improvement.

Phototherapy for Vitiligo

Narrow-band UVB (NB-UVB) phototherapy is one of the most established treatment options for widespread or actively progressing vitiligo.

The treatment exposes affected skin to carefully controlled amounts of narrow-band ultraviolet B light. It can encourage repigmentation by stimulating pigment-producing cells and their activity in the affected skin.

NB-UVB is widely used for vitiligo and does not require the photosensitising medication used with PUVA. Treatment is usually given several times a week and may continue for many months.

The main challenge is patience.

A systematic review and meta-analysis published in JAMA Dermatology looked at 35 studies involving 1,428 patients. At least mild repigmentation was reported in about 74% of patients after six months and 75% after 12 months. A more substantial response, defined in the review as at least 75% repigmentation, occurred in about 19% at six months and 36% at 12 months.

Response also varied significantly by body area. Marked responses were highest on the face and neck and much lower on the hands and feet.

This is important when setting expectations: vitiligo treatment can work, but not every patch responds equally well.

Combining Treatments May Improve Results

Sometimes, one treatment isn’t enough.

Dermatologists may combine different approaches when appropriate. For example, phototherapy can be used alongside topical medicines to improve repigmentation.

Research has also been looking at combinations involving ruxolitinib and NB-UVB. A 2025 phase 2 study reported improved repigmentation after NB-UVB was added to ruxolitinib cream in patients who had not responded sufficiently to ruxolitinib alone during the initial treatment period.

This doesn’t mean everyone with vitiligo needs combination treatment. The right approach depends on factors such as disease activity, affected body areas, previous treatment, age, and how the skin responds.

If one treatment isn’t producing enough improvement after several months, talk to your dermatologist about whether adding another treatment or changing the approach could make sense rather than assuming that nothing will work.

Emerging and Advanced Treatments

Vitiligo research continues to evolve, particularly around treatments that target the immune pathways involved in melanocyte destruction.

Newer JAK inhibitors and other targeted therapies are being studied, while existing treatments are increasingly being investigated in combination with phototherapy.

For people with stable vitiligo that has not responded adequately to medical treatment, surgical approaches may also be considered.

These include:

• Autologous melanocyte or melanocyte-keratinocyte transplantation
• Suction blister grafting
• Split-thickness skin grafting
• Punch grafting

The basic idea is to move pigment-producing cells or pigmented skin from an unaffected area to areas affected by vitiligo.

Surgery is not suitable for everyone. It is generally considered when vitiligo has remained stable for a sustained period, and medical treatment has not produced satisfactory repigmentation. A 2025 consensus statement on surgical management defines stable vitiligo as no new patches or enlargement of existing lesions for at least one year, although individual circumstances can affect the decision.

For some people with stable, treatment-resistant vitiligo, surgery can offer another avenue for repigmentation when conventional treatments have not provided the desired results.

How Long Does Vitiligo Treatment Take to Work?

This is one of the most important things to know before starting treatment: vitiligo treatment usually takes months, not weeks.

Topical treatments and phototherapy may need several months before noticeable repigmentation becomes apparent. With phototherapy, studies show that responses can continue to improve with longer treatment.

JAK inhibitor creams such as ruxolitinib also require patience. In clinical trials, some patients achieved substantial facial repigmentation by 24 weeks, while treatment can continue beyond that point for additional benefit.

The timeline also depends on where the vitiligo appears. The face and neck tend to respond better than areas such as the fingers, hands, feet, and toes.

So if you don’t see a dramatic change after a few weeks, don’t automatically assume that treatment has failed. Your dermatologist can assess whether the treatment needs more time, whether it is producing early signs of repigmentation, or whether another approach should be considered.

Choosing the Right Treatment for You

There is no single best treatment for vitiligo that works for everyone.

Your dermatologist may consider:

• Whether your vitiligo is segmental or non-segmental
• Whether the condition is stable or actively spreading
• How much of the body is affected
• Which areas are affected
• Your age and overall health
• Previous treatments and how your skin responded
• Your personal treatment goals and preferences

For example, someone with a few patches on the face may have very different treatment needs from someone with widespread or actively progressing vitiligo.

This is why seeing a dermatologist matters. Treatment should be based on your individual situation rather than simply choosing the option that appears most effective online. The American Academy of Dermatology also notes that there is no single best treatment for everyone and that treatment plans are individualized according to factors such as age, health, vitiligo type, location, and whether the condition is spreading.

It is also worth considering the practical side of treatment. Phototherapy may require repeated clinic visits, while topical and JAK inhibitor treatments require consistent use over months. Surgical treatment involves procedures, recovery, and follow-up care.

Cost can become another consideration, particularly when treatment continues for months or requires repeated appointments. Insurance coverage for vitiligo treatment varies considerably by country, insurer, policy, and treatment, so check your coverage and expected out-of-pocket costs before starting a long-term treatment plan.

If you’re concerned about the cost, your dermatologist or hospital may also be able to suggest lower-cost treatment alternatives or available financial assistance programmes.

Conclusion

Vitiligo treatment has come a long way. There is still no permanent cure, but topical medicines, phototherapy, targeted treatments such as ruxolitinib, and surgery for selected stable cases can help restore lost skin colour. The key is patience: results take time, and some areas respond better than others. If treatment is not giving you the improvement you hoped for, speak with your dermatologist before giving up. And if you are facing a separate, eligible medical expense that is difficult to afford, platforms such as ImpactGuru can help qualifying patients explore medical crowdfunding as one possible source of financial support.